Quertle is an artificial intelligence company focused on text discovery and understanding in the biomedical and life sciences fields. Published information is the foundation for the entire healthcare industry – from basic research to drug discovery to clinical trials to healthcare delivery and everything in between including business aspects. Quertle's flagship product Qinsight enables unparalleled discovery of literature through AI-powered searching, integration, organization, and presentation including predictive visual analytics. Qinsight, which covers journal articles, patents, clinical trials, treatment protocols and much more, is in use by pharmaceutical and biotechnology companies, universities, research centers, and healthcare providers around the world. Quertle was founded by Jeffrey Saffer and Vicki Burnett – Ph.D. biomedical scientists who were frustrated with the inefficiencies in discovering critical publications and the waste caused by missing information.

Quertle is an artificial intelligence company focused on text discovery and understanding in the biomedical and life sciences fields. Published information is the foundation for the entire healthcare industry – from basic research to drug discovery to clinical trials to healthcare delivery and everything in between including business aspects. Quertle's flagship product Qinsight enables unparalleled discovery of literature through AI-powered searching, integration, organization, and presentation including predictive visual analytics. Qinsight, which covers journal articles, patents, clinical trials, treatment protocols and much more, is in use by pharmaceutical and biotechnology companies, universities, research centers, and healthcare providers around the world. Quertle was founded by Jeffrey Saffer and Vicki Burnett – Ph.D. biomedical scientists who were frustrated with the inefficiencies in discovering critical publications and the waste caused by missing information.

HENDERSON, Nev.--(BUSINESS WIRE)--Quertle LLC has developed the first artificial intelligence and visual analytics big data (BioAI) platform for biomedical drug discovery. This platform combines machine learning, neural networks, and other AI methods to improve discovery and insight. The BioAI platform includes predictive visual analytics that accelerate search and discovery from the literature, enable discovery of documents that are otherwise overlooked and improve drug discovery. The AI-powered visualizations summarize an entire set of documents, detect trends and uncover hidden connections. Biomedical literature is the foundation of the 5 trillion health care market, serving as the basis for drug discovery, medical device opportunities, marketing decisions and direct health care.